Search Results 201-210 of 12342 for Multiple myeloma red flag
"We found that treatment of smoldering myeloma delays progression to symptomatic myeloma and can prevent damage to organs that occurs in multiple myeloma.
Learn about this cancer that forms from white blood cells called plasma cells. Treatments include medicines and bone marrow transplant.
Research. Mayo Clinic doctors and scientists have been on the forefront of multiple myeloma research for more than 50 years. They have contributed important ...
... multiple myeloma. Dinaciclib and bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in ...
The purpose of this study is to establish a prospective cohort of individuals with precursor conditions to multiple myeloma, such as monoclonal gammopathy of ...
The purpose of this study is to understand more about how multiple myeloma and its treatment affect day-to-day life for patients, with particular interest in ...
The study applies specifically to patients with standard-risk multiple myeloma who did not receive an upfront stem cell transplant. Additional studies are ...
... multiple myeloma (MM) who have exhausted all therapeutic options that ... Patients must have symptomatic myeloma at the time of study entry with myeloma ...
Study Of Pomalidomide And Low Dose Dexamethasone With Or Without Pembrolizumab (MK-3475) In Refractory Or Relapsed And Refractory Multiple Myeloma (RrMM) (MK- ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.